Total synthesis of duocarmycin prodrugs

ORGN 741

Meritxell Guinó, meritxell.guino@pharmacy.ac.uk1, Laurence H. Patterson, l.h.patterson@bradford.ac.uk2, and Mark Searcey, mark.searcey@pharmacy.ac.uk1. (1) Pharmaceutical and Biological Chemistry, The School of Pharmacy, University of London, 29/39 Brunswick Square, London, WC1N 1AX, United Kingdom, (2) The Institute of Cancer Therapeutics, University of Bradford, Richmond Road, Bradford, BD7 1DP, United Kingdom
Duocarmycins are an exceptionally potent class of antitumour antibiotics, which exert their activity through a sequence-selective alkylation of the N2 of adenine in the minor groove of DNA. The main drawback of these alkylating agents is their toxicity towards all proliferating cells. Therefore, the development of potent cytotoxic prodrugs which undergo cytochrome P450 (CYP)-mediated activation in the tumour, will lead to selective cell killing. The total synthesis of duocarmycin analogues will be described. The key step towards the total synthesis of these prodrugs is a free radical cyclisation in order to form the 5-membered ring attached to the indole (Figure 1). Results of the in vivo and in vitro cytotoxicity of the compounds prepared will be reported. Studies on new approaches towards the stereoselective total synthesis of the most potent duocarmycin prodrug derivative will be also presented.